International Journal of Gynecological Cancer

Treatment options in bulky stage IB cervical carcinoma
pp. 1153-1162(10)
Authors: PETSUKSIRI,; CHANSILPA,; THERASAKVICHYA,; SUNTORNPONG,; THEPHAMONGKHOL,; DANKULCHAI,; MAHASITTHIWAT,; IEUMWANANONTHACHAI,; VEERASARN,; SANGRUCHI,; PATTARANUTAPORN,

Lymphatic mapping in endometrial cancer: a literature review of current techniques and results
pp. 1163-1168(6)
Authors: KHOURY-COLLADO,; ABU-RUSTUM,

Alteration of cell-cycle regulation in epithelial ovarian cancer
pp. 1169-1182(14)
Authors: NAM,; KIM,

Long-term adjustment of early-stage ovarian cancer survivors
pp. 1183-1193(11)
Authors: MATULONIS,; KORNBLITH,; LEE,; BRYAN,; GIBSON,; WELLS,; SULLIVAN,; PENSON,

Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer
pp. 1194-1199(6)
Authors: NGUYEN,; WRIGHT,; POWELL,; GIBB,; RADER,; ALLSWORTH,; MUTCH,

Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus
pp. 1200-1201(2)
Authors: HOSKINS,; LE,

Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety
pp. 1202-1209(8)
Authors: PARK,; BAE,; LIM,; SEO,; KANG,

Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer
pp. 1210-1214(5)
Authors: NAGAO,; FUJIWARA,; OHISHI,; NAKANISHI,; IWASA,; SHIMIZU,; GOTO,; SHIMOYA,

A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma
pp. 1215-1233(19)
Authors: GYÖRFFY,; DIETEL,; FEKETE,; LAGE,

Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas
pp. 1234-1247(14)
Authors: WOO,; SALAMANCA,; MILLER,; SYMOWICZ,; LEUNG,; OLIVEIRA,; EHLEN,; GILKS,; HUNTSMAN,; AUERSPERG,

cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation
pp. 1248-1257(10)
Authors: LINNERTH,; GREENAWAY,; PETRIK,; MOOREHEAD,

High-intensity electric pulses induce mitochondria-dependent apoptosis in ovarian cancer xenograft mice
pp. 1258-1261(4)
Authors: LI,; HU,; DONG,; SUN,; MI,

Claudin-7 expression in human epithelial ovarian cancer
pp. 1262-1271(10)
Authors: TASSI,; BIGNOTTI,; FALCHETTI,; RAVANINI,; CALZA,; RAVAGGI,; BANDIERA,; FACCHETTI,; PECORELLI,; SANTIN,

Total tissue lactate dehydrogenase activity in endometrial carcinoma
pp. 1272-1278(7)
Authors: ŠIMAGA,; ABRAMIĆ,; OSMAK,; BABIĆ,; ILIĆ-FORKO,

The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients
pp. 1279-1284(6)
Authors: KOTOWICZ,; FUKSIEWICZ,; KOWALSKA,; JONSKA-GMYREK,; BIDZINSKI,; KAMINSKA,

Endocervical adenocarcinoma associated with lobular endocervical glandular hyperplasia showing rapid reaccumulation of hydrometra
pp. 1285-1288(4)
Authors: TAKEUCHI,; TSUJINO,; SUGIMOTO,; YOSHIDA,; KITAZAWA,

The impact of microinvasive cancer of the cervix on women during follow-up
pp. 1289-1293(5)
Authors: CAIRNS,; GRAY,; CRUICKSHANK,

Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery
pp. 1294-1299(6)
Authors: ATAHAN,; OZYAR,; YILDIZ,; OZYIGIT,; GENC,; ULGER,; USUBUTUN,; KÖSE,; YUCE,; AYHAN,

Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix
pp. 1300-1304(5)
Authors: KODAMA,; TAKEMOTO,; SEKI,; NAKAMURA,; HONGO,; MORIYA,; KANAZAWA,; HIRAMATSU,

Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci-review of more than 25 biopsies from five patients
pp. 1305-1314(10)
Authors: KAMOI,; OHAKI,; MORI,; KUROSE,; FUKUNAGA,; TAKESHITA,

Laparoscopically assisted versus open surgery for endometrial cancer—a meta-analysis of randomized controlled trials
pp. 1315-1325(11)
Authors: LIN,; ZHANG,; ZHENG,; ZHAO,; ZENG,; ZHU,

Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study
pp. 1326-1331(6)
Authors: LÉCURU,; LE FRÈRE BELDA,; BATS,; TULPIN,; METZGER,; OLSCHWANG,; LAURENT-PUIG,

Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients
pp. 1332-1338(7)
Authors: PARK,; KIM,; NAM,

Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma
pp. 1339-1343(5)
Authors: KANG,; SEO,; CHANG,; YOO,; PARK,; DONG,

Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation
pp. 1344-1351(8)
Authors: SINGH,; SMITH,; CHEETHAM,; DODD,; DAVY,

Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker
pp. 1352-1359(8)
Authors: KIM,; SONG,; LEE,; YEOM,

Primary fallopian tube carcinoma associated with ovulation induction; a case report
pp. 1360-1363(4)
Authors: DELIVELIOTOU,; HASSIAKOS,; FOTIOU,; KARVOUNI,; CREATSAS,

Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation
pp. 1364-1367(4)
Authors: BRADLEY,; DOTTINO,; RAHAMAN,

High-dose density chemotherapy followed by simple trachelectomy: full-term pregnancy
pp. 1367-1371(5)
Authors: ROBOVA,; PLUTA,; HREHORCAK,; SKAPA,; ROB,

Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review
pp. 1371-1376(6)
Authors: YEASMIN,; NAKAYAMA,; ISHIBASHI,; ORIDE,; KATAGIRI,; PURWANA,; IIDA,; ISHIKURA,; MIYAZAKI,

Chemotherapy for gynecological malignancies in organ transplantation patients: report of two cases
pp. 1376-1380(5)
Authors: TAO,; KAVANAGH,

First case of vaginal radical trachelectomy in a pregnant patient
pp. 1381-1385(5)
Authors: van de NIEUWENHOF,; van HAM,; LOTGERING,; MASSUGER,

Response to letter of Escobar et al.
pp. 1386-1386(1)

Are we spending unnecessarily on postmenopausal women who present with bleeding?
pp. 1387-1387(1)

Erratum
pp. 1388-1388(1)